Physician profile
Jordan E Lake
NPI 1700032075
$35,424.70
in general payments reported to CMS, 2019-2025
8 companies · $8,660 in 2025
The $8,660 reported for 2025 was more than what 92% of Infectious Disease providers received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $446 · 2020: $11K · 2021: $9,103 · 2022: $2,550 · 2023: $111 · 2024: $3,920 · 2025: $8,660.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Travel and Lodging: $552 · Food and Beverage: $343 · Education: $10.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,784.00 |
| Travel and Lodging | $552.45 |
| Food and Beverage | $343.46 |
| Education | $10.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $13,655.67 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $9,968.14 | 2019-2023 | Delstrigo |
| Theratechnologies INC. | $7,250.00 | 2020-2022 | |
| Viiv Healthcare Company | $3,655.91 | 2020-2025 | Dovato |
| Janssen Scientific Affairs, LLC | $550.00 | 2022 | |
| Melinta Therapeutics, LLC | $271.92 | 2019 | |
| Tetraphase Pharmaceuticals, INC. | $73.06 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Lake listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.